[Frontiers in Bioscience 14, 717-730, January 1, 2009]

Regulation of epithelial junctions by proteins of the ADP-ribosylation factor family
Toyoko Hiroi

Johns Hopkins University School of Medicine, Division of Cardiology, 1721 East Madison Street, Ross Research Building Room 1167, Baltimore, MD 21205

TABLE OF CONTENTS

1. Abstract
2. Introduction
3. ADP-ribosylation factor (ARF) family
3.1. ARFs
3.2. Regulators of ARFs: guanine nucleotide exchange factors and GTPase-activating proteins
3.3. Functional properties of ARFs
4. Tight junctions
5. Adherens junctions
5.1. E-cadherin
5.2. Alpha-Catenin
5.3. Vinculin and alpha-Actinin
6. Desmosomes
7. Focal adhesions
7.1. Integrin
7.2. Filamin
7.3. Other proteins associated with focal adhesions
8. Cytoskeleton
8.1. Actin
8.2. Intermediate filament
9. Concluding remarks
10. Acknowledgment
11. References

1. ABSTRACT

ADP-ribosylation factor (ARF) proteins play a pivotal role in the regulation of membrane traffic and the organization of the cytoskeleton that are crucial to fundamental cellular processes, such as intracellular sorting/trafficking of newly synthesized proteins and endocytosis/exocytosis. In epithelial junctions, the ARF proteins are intimately associated with the dynamics of transmembrane proteins, such as E-cadherin and beta-1 integrin, and the adaptor proteins such as paxillin. In addition, ARF proteins play a key regulatory role in the remodeling of actin cytoskeleton necessary for the formation of membrane ruffles and protrusions in association with phospholipase D and members of the Rho GTPase family. These activities of ARF proteins influence not only the formation, stability and functional integrity of epithelial junctions but also the cell motility as well. In this review, I have attempted to provide a compendium of evidence that has contributed to our evolving understanding of these ARF proteins as well as their regulators (guanine nucleotide exchange factors and GTPase-activating proteins) in the regulation of epithelial junctions. In addition, I also have also highlighted potential mechanisms as to how these intricate regulatory pathways are regulated both spatially and temporally.

2. INTRODUCTION

In this review, I will try to recapitulate the emerging evidence that dictates a pivotal role for ARF proteins in the formation and function of epithelial junctions. In epithelial tissue, cells are tightly bound together and are organized into sheets called epithelia. In epithelia, the cells are attached to each other by cell-cell adhesions, which bear most of the mechanical stresses. Specialized cell junctions occur at points of cell-cell and cell-matrix contacts in all tissues, and they are particularly ubiquitous in epithelia. Based on the nature of interface, the cell-cell contacts are classified into tight junctions (TJs), adherens junctions (AJs), gap junctions or desmosomes, whereas cell-matrix adhesions are classified as hemidesmosomes or focal adhesions/contacts (FAs). Small GTPases of Ras superfamily play a pivotal role in the epithelial biogenesis. They mediate an increasingly complex interplay between cell-cell adhesion molecules and fundamental cellular processes such as cytoskeletal activity, vesicular trafficking, cellular polarization and stabilization. In addition, they are also involved in the pathologic cellular processes of cellular transformation such as epithelial-mesenchymal transformation (1, 2).

Here, I will focus on the role of ARF proteins, a family of small GTPases, in the biogenesis and function of epithelial junctions. I will discuss how ARF proteins regulate the molecular composition at the epithelial junctions and how this regulation by ARF proteins influences the function of epithelial junctions and cellular activity. Obviously this is an extremely complex field and many aspects of these intricate regulatory pathways remain to be elucidated. Accordingly, I will strive to highlight key issues that challenge the field, in the hope that such discussions might stimulate and foster further research and collaborations across different disciplines.

3. ADP-RIBOSYLATION FACTOR FAMILY

3. 1. ARFs

ARF proteins are a family belonging to the Ras superfamily of small GTPases (3). ADP-ribosylation factors (ARFs) were initially purified as cofactors for cholera-toxin catalyzed ADP-ribosylation of the alpha-subunit of heterotrimeric G proteins, Gs, and then identified as GTP binding proteins in vitro assays (4, 5). However, now it is well established that ARF family is involved in many intracellular processes including vesicular biogenesis and intracellular trafficking (reviewed in 6-10).

ARF proteins are soluble proteins that generally associate with membranes via N-terminal myristoylation and are ubiquitous in all eukaryotes from yeast to humans. Currently, ARF family is composed of six mammalian ARFs and many other ARF-like proteins (reviewed in 11, 12). A total of 29 members have been identified in humans. The six principal mammalian ARF members are divided into three classes based on their amino-acid sequence similarity. Class I ARF members (ARF1, ARF2 and ARF3) share among themselves more than 94% amino-acid sequence homology. They localize to the Golgi apparatus and are involved in the trafficking of endoplasmic reticulum - Golgi and endosomal systems. Class II ARF members, ARF4 and ARF5, are 90% identical to each other and show approximately 80% identical with that of class I ARFs. They also localize to the Golgi apparatus as class I ARFs but are less abundant than class I ARFs. In contrast to class I ARFs, the function of class II ARFs remains poorly understood. Class III has only a solitary member, ARF6 that shares 65 - 70% amino acid homology with other ARFs and localizes at the cell periphery.

3.2. Regulators of ARFs: guanine nucleotide exchange factors and GTPase-activating proteins

Similar to other Ras-related GTP-binding proteins, the ARF proteins cycle between GTP-bound active state and GDP-bound inactive state. ARFs bind to GTP tightly but have a very low intrinsic activity of GTP hydrolysis (5). Their GTPase cycle is regulated by guanine nucleotide exchange factors (GEFs) that exchange GDP for GTP on ARFs lead to their activation. Conversely, GTPase-activating proteins (GAPs) that hydrolyze bound GTP to GDP deactivate these ARFs.

All ARF GEFs share a 200-amino acid, Sec 7 domain module, that catalyzes the exchange of GDP for GTP on ARFs, thus, being referred to as the Sec7 family. The fungal fatty acid metabolite brefeldin A (BFA), which disassembles the Golgi complex and blocks protein secretion, directly inhibits some of ARF GEFs, but not all. BFA binds to the ARF-GDP-ARF GEF complex, and prevents the conformational changes that are required for GEFs to release the bound GDP, resulting in failure to activate ARFs (13-15). So far, there are fifteen members of human ARF GEFs that have been identified and these are classified into five groups, GBF/BIG, PSCD/Cytohesins, PSD/EFA6s, IQSEC/BRAGs and Fbox, based on their overall structure and domain organization (Table 1)(16).

All known ARF GAPs contain a well-conserved ARF GAP domain, that is necessary for GAP activity. In mammals, at present, 24 proteins with ARF GAP domains have been identified and these 24 members are classified into two types, ArfGAP and AZAP, based on their overall structure and each type is further subdivided according to domain organization (Table 2)(17). Originally ARF GAPs were identified as negative-regulators of ARFs and they have been implicated in membrane trafficking of vesicle coats by inactivating ARF activity (18, 19). These ARF GAPs are structurally complex and contain multiple domains/motifs in addition to their ARF GAP domain that is common to all the members. Through these complex domains, ARF GAPs interact with a variety of proteins and have been shown to be involved in many different intracellular processes and functions including those of membrane trafficking, regulation of actin cytoskeleton and signaling both dependently and independently of ARFs.

The presence of a large number of ARF GEFs and ARF GAPs that are capable of modulating the activities of relatively few ARFs implies a complex and intricate regulatory mechanism operational in various subcellular compartments to coordinately regulate ARFs temporally or spatially in response to various stimuli or upstream events.

Considering the fact that a single molecule may be referred to by several different names in the published literature, the nomenclature of ARF GEFs and ARF GAPs in this review represents gene symbol/alternate name given in published reports for each ARF GEF or ARF GAP.

3.3. Functional properties of ARFs

Among the six ARF members, ARF1 and ARF6 are the most extensively studied. ARF1 localizes to the Golgi complex and has been implicated in the endoplasmic reticulum to Golgi transport, organization and function of the Golgi, transport from the trans-Golgi network, transport in the endocytic pathway and regulation of enzymes that modify membrane phospholipids (6, 7, 20-26).

Unlike ARF1, ARF6 has no effect on Golgi membrane dynamics. ARF6 localizes at the cell periphery and is implicated in the regulation of plasma membrane-endosomal trafficking and structural organization of the peripheral plasma membrane, such as endocytosis/recycling of membrane proteins (27-30), exocytosis/secretion of proteins (31-33), phagocytosis (34-36), cell migration (37-40), cell spreading / scattering (41, 42), Rac-induced membrane ruffling (40, 43, 44), actin cytoskeleton remodeling (45, 46), neurite outgrowth (47, 48) cytokinesis and in the activation of enzymes that modify membrane phospholipids (49, 50).

There are several excellent and comprehensive reviews that discuss the cellular functions of ARFs, ARF GEFs and ARF GAPs for those readers who are interested in an in-depth view (6-9, 16, 17, 51).

4. TIGHT JUNCTIONS

Tight junctions (TJs) are a type of occluding junctions found in vertebrates and these TJs seal neighboring cells together in an epithelial sheet to prevent even small molecules and water from passing through paracellular pathways. They serve as barriers between the apical and basolateral membranes, which is one of the basic functions of epithelia. TJs also prevent the diffusion of membrane proteins and lipids which are important in the maintenance of cell polarity and directional transport between apical and basolateral domains. TJs are composed of several proteins including transmembrane proteins such as claudins and occludin, the scaffold proteins such as cingulin and ZO proteins, with which transmembrane proteins interact (52).

Polarized Madin-Darby canine kidney (MDCK) cells that overexpress PSD/EFA6A, a GEF specific for ARF6, show accelerated kinetics of the assembly or a delay in the kinetics of disassembly of TJs (53). This effect requires the Sec7 domains and the C-terminal domains of PSD/EFA6A that are essential for the GDP-GTP exchange activity and membrane localization, respectively, suggesting that this effect of PSD/EFA6A on TJs requires ARF6 activation. In addition, selective retention of occludin at the cell surface along with strong apical actin and ZO-1 accumulation were observed in these cells overexpressing PSD/EFA6A, indicating that PSD/EFA6A enhances the stabilization of protein complexes including actin cytoskeleton at the TJs. The precise molecular mechanism responsible for this effect remains unclear, however, PSD/EFA6 is involved in the regulation of endocytic vesicles as well as actin remodeling (54-56) and it has been shown that PSD/EFA6 promotes the redistribution of membrane receptors to the cell surface by regulating ARF6 and Rac1 (55). This retention of occludin imparts stability to the TJs. Indeed, the TJs in cells overexpressing PSD/EFA6A were more stable than in controls cells (53). Cell polarity was retained in MDCK cells overexpressing PSD/EFA6A or a GTPase-defective ARF6 mutant, ARF6(Q67L) (37, 53). In further support of ARF6 and PSD/EFA6A involvement in TJs, the overexpression of wild-type ARF6 in MDCK cells led to its localization to the apical surface of these cells (28) while the overexpression of PSD/EFA6A resulted in the distribution of this protein at TJs along with ZO-1 protein (53).

5. ADHERENS JUNCTIONs

Adherens junctions (AJs) are a type of anchoring junctions that are most abundant in tissues subjected to severe mechanical stress. They also play a key role in the formation and maintenance of TJs and desmosomes. AJs consist of two basic adhesive units: classical cadherin-catenin complex and nectin-afadin complex (57). In the classical cadherin-catenin complex, the intracellular anchor proteins, such as catenins, vinculin, and alpha-actinin, form a distinct plaque on the cytoplasmic face of the plasma membranes and connect the junctional complexes to actin cytoskeleton. Transmembrane adhesion proteins of the cadherin-catenin complex belong to the cadherin family. In the nectin-afadin complex, nectin, a transmembrane IgG-like adhesion protein, forms a structural adhesive unit with afadin, which is an actin-binding protein. However, at the present, there is no evidence to implicate ARFs in the regulation of nectin-afadin complexes.

5.1. E-cadherin

E-cadherin is the predominant cadherin found in the epithelial cadherin-catenin complexes. The newly synthesized E-cadherin binds to beta-catenin and gets transported to lateral membranes of the epithelial cells to be assembled into AJs (58). E-cadherin on the epithelial cell surface undergoes constitutive internalization to enter early endosomal compartments (59- 62) and then gets recycled back to surface plasma membranes. In addition to being constitutively active in polarized cells, the disruption of AJs and internalization of E-cadherin occur during cell scattering induced by growth factors (37). A similar loss of E-cadherin function and disassembly of AJs are seen in epithelial tumor invasion and metastasis (37, 57, 63).

The regulation of E-cadherin by ARF6 has been extensively studied and well documented. Activation of ARF6 is required for hepatocyte growth factor (HGF)-induced scattering activity of MDCK cells (37, 42). Activation of ARF6 in MDCK cells promotes clathrin-dependent internalization of E-cadherin, resulting in the disassembly of AJs, (37). Similar evidence has been found in MCF-7 cells that overexpress the GTPase-defective ARF6 mutant, ARF6(Q67L) (61). The molecular mechanism underlying the ARF6 involvement in the AJ disassembly operates via recruitment of Nm23-H1. Nm23-H1 is a nucleoside disphosphate kinase that facilitates dynamin-mediated internalization of E-cadherin during AJ disassembly. Nm23-H1 also decreases Rac1-GTP levels at the cell junctions (59). Activation of Rac1 has been implicated in the accumulation of actin at the AJs (64-66). Thus, the downregulation of Rac1 by Nm23-H1 probably leads to a decrease in actin fibers at the AJs and also facilitates the disassembly of these AJs. Consistent with this notion, a demonstrable reduction in actin staining has been reported during ARF6-mediated disassembly of AJs (37).

A GEF for ARF6 (IQSEC1/BRAG2/ GEP100), was also shown to be involved in the regulation of E-cadherin (67). Ablation of IQSEC1/BRAG2/GEP100 expression by siRNA treatment in hepatocellular carcinoma HepG2 cells results in an increase of E-cadherin protein levels and also alters its intracellular distribution after HGF treatment (68). In control cells, E-cadherin was internalized and diffusely distributed in the cytoplasm upon HGF treatment, while in where IQSEC1/BRAG2/GEP100 knockdown cells, E-cadherin remained at the cell periphery, suggesting that IQSEC1/BRAG2/GEP100 is likely to be involved in the HGF-induced internalization of E-cadherin. Recently, IQSEC1/BRAG2/GEP100 has also been implicated in the cell invasiveness of breast cancer cells (69). In this study, co-overexpression of ARF6 and IQSEC1/BRAG2/GEP100, but not its mutant lacking the Sec7 domain, in breast cancer cells resulted in the impairment of E-cadherin-mediated cell-cell adhesion after treatment with epidermal growth factor (EGF). In addition, co-overexpression of ARF6 and IQSEC1/BRAG2/GEP100 induced invasive activity upon EGF stimulation. However, PSCD2/Cytohesin-2/ARNO, one of the other GEFs that regulate ARF6, did not result in any invasive activity. Moreover, overexpression of PSD/EFA6A also failed to demonstrate any effect on intracellular distribution of E-cadherin in MDCK cells (53). Taken together, these observations suggest that ARF6 in conjunction with IQSEC1/BRAG2/GEP100 play an important role in the regulation of E-cadherin-mediated cellular functions. In MDCK cells that overexpressed a dominant negative ARFGEF2/BIG2 mutant, ARFGEF2/BIG2(E738K), the E-cadherin-beta-catenin complexes at the AJs were disrupted and these disrupted E-cadherin-beta-catenin complexes co-localized with the Golgi maker GM130 in the perinuclear cytoplasm, suggesting that E-cadherin and beta-catenin were arrested in the Golgi in such cells (70). ARFGEF2/BIG2 predominantly activates class I ARFs (ARF1 and ARF3)(71). Thus, ARFGEF2/BIG2 and probably class I ARFs are involved in the transport of E-cadherin and beta-catenin from the Golgi apparatus to the cell surface.

5.2. Alpha-catenin

In the cadherin-catenin complexes, alpha-catenin interacts with E-cadherin via beta-catenin and also binds to actin. Alpha-catenin was long considered to be a linker between the AJs and actin fibers but more recent evidence suggests that alpha-catenin is likely to serve as a molecular switch that coordinates the functions of AJs in the cell-cell interactions as well as actin cytoskeleton in the cell motility (72-74).

Alpha-catenin was identified as an IQSEC1/BRAG2/GEP100-binding protein in yeast two hybrid screens (68). This physical interaction between alpha-catenin and IQSEC1/BRAG2/GEP100 was confirmed by coimmunoprecipitation studies, but not by immunofluorescent assays. The ablation of IQSEC1/BRAG2/GEP100 expression by siRNA resulted in increased levels of alpha-catenin in the cells (68). In the presence of alpha-catenin, GTP binding activity of ARF6 which is IQSEC1/BRAG2/GEP100 dependent, increases modestly in in vitro studies (68). These findings thus imply that alpha-catenin, ARF6 and IQSEC1/BRAG2/GEP100 form a functional ternary regulatory complex but direct evidence for their intracellular physical association remains elusive.

5.3. Vinculin and alpha-Actinin

Both vinculin and alpha-actinin are cytoskeletal proteins that associate with AJs as well as focal adhesions (FAs), and serve as linker proteins. Vinculin has binding sites for several molecules, including talin, alpha-actinin, alpha-catenin, paxillin and actin. The activities of vincluin and alpha-actinin are regulated by phosphatidylinositol (4, 5)-bisphosphate (PI(4,5)P2) and phospholipase D2 (PLD2) (75-81).

Only limited information exists in literature in support of ARF involvement in the regulation of vinculin and alpha-actinin functions. It has been shown that the intracellular distribution of vinculin is not altered by ARF1 or DDEF1/ASAP1/PAG2, one of GAPs (82, 83). In yeast two-hybrid screens with an adult mouse brain cDNA library, alpha-actinin was identified as a possible interacting protein with PSD/EFA6A, and partly colocalized with PSD/EFA6A in mouse brain tissues as well as cultured hippocampal neurons as determined by immunofluorescent studies (84). Another actin binding protein, alpha-catenin, as mentioned above, has also been identified as an interacting protein of IQSEC1/BRAG2/GEP100 (68). Both PSD/EFA6A and IQSEC1/BRAG2/GEP100 are ARF GEFs specific for ARF6 which has been demonstrated to be involved in actin remodeling. The physiological significance of the binding of these ARF6 specific GEFs to actin-binding proteins remains to be established. In in vitro binding analyses, ARF1 disrupted the interaction between PLD2 and alpha-actinin in a concentration-dependent manner and ablated the down-regulation of PLD2 activity by alpha-actinin (81). PLD2, which is predominantly associated with the plasma membranes, has been implicated in the cytoskeletal dynamics (85). Phosphatidic acids, a PLD2 metabolite, can enhance PI(4,5)P2 levels by activation of type I phosphatidylinositol phosphate 5 kinase (PIP5K). PI(4,5)P2, on the other hand, regulates both actin-binding activity of alpha-actinin as well as cytoskeletal dynamics. Therefore, regulation of PLD2 activity by alpha-actinin is likely to affect both actin skeletal dynamics as well as alpha-actinin activity itself. The regulatory loop of alpha-actinin and PLD2 is also likely to be impacted by ARF1 (81).

6. DESMOSOMES

Desmosomes are a type of anchoring junctions particularly important for maintaining the integrity of tissues that endure physical stress. These junctions have a dense cytoplasmic plaque composed of intercellular anchor protein complexes, such as plakoglobin, desmoplakin and plakophilins, that are responsible for connecting the cytoskeleton to transmembrane adhesion proteins, for example desmogleins and desmocollins (86).

ARF6 regulates plasma membrane-endosomal trafficking of various proteins located in the plasma membranes, such as major histocompatibility complex class I (MHC I) and various receptors (29, 30, 87-89). In HeLa cells overexpressing GTPase-defective ARF6 mutant, ARF6(Q67L), plakoglobin and MHC I were found in the actin-rich vacuolar compartment induced by ARF6(Q67L) (90), suggesting the possibility that the plasma membrane-endosomal dynamics of plakoglobin is regulated by ARF6.

7. FOCAL ADHESIONS

Focal adhesions (FAs) are a type of anchoring junctions found in the cell-extracellular matrix (ECM) interface. FAs serve as mechanical linkages to the ECM, as well as biochemical signaling centers. Therefore, numerous proteins including those of structural proteins, enzymes and adaptor proteins are concentrated and directed to the FAs. Transmembrane adhesion proteins that structurally support FAs belong to the integrin family. The intracellular domains of integrins bind indirectly to bundles of actin filaments via intracellular anchor proteins talin, alpha-actinin, filamin and vinculin. Many other intracellular proteins that are associated with signaling, such as focal adhesion kinase (FAK) and PKC, also bind to and associate with this integrin-adaptor protein-cytoskeleton complexes, thus forming the basis of FAs. The dynamic assembly and disassembly of focal adhesions play a central role in the cell migration. During cell migration, both the composition and the morphology of these FAs undergo striking changes (91).

7.1. Integrins

Integrins are heterodimeric transmembrane glycoproteins comprising of diverse alpha- and beta subunits (92). Twenty-four different alpha subunits are known to exist that can link in many different combinations with nine different beta subunits. In epithelial cells, the predominant subunit is beta1-integrin.

ARF6 controls recycling of beta1-integin from internal compartments to plasma membrane (93). The expression of a dominant-negative mutant ARF6(T27N) had no effect on the internalization of beta1-integin to recycling endosomes but increased internal beta1-integin, that significantly colocalized with ARF6. Another ARF6 mutant ARF6(Q37E/S38I), which selectively inhibits actin arrangement but not ARF6-mediated transport, also had the same inhibitory effects as ARF6(T27N) on beta1-integin recycling. A dominant-negative Rab11(S25N) also abrogated the recycling of beta1-integin, indicating that the recycling of beta1-integin to plasma membranes is regulated by both ARF6 and Rab11 as well as requires actin cytoskeleton arrangement in an ARF6 dependent manner. Consistent with this observation, internal beta1-integin was found in the PIP2-positive vacuolar compartment induced by ARF6(Q67L) (90) and in cells with knocked down ARF6, beta1-integrin levels at the cell surface was reduced (94). Beta1-integin levels at the cell surface correlate with its function. Indeed, the cells with knocked down ARF6 spread less efficiently on fibronectin-coated substrates. CENTB1/ACAP1, that is a GAP for ARF6 as well as an effector in cargo sorting (95-97), is also shown to plays an important role in beta1-integin recycling (98). Both overexpression and abrogation of CENTB1/ACAP1 by siRNA treatment inhibited the recycling of beta1-integin, and beta1-integin was colocalized with CENTB1/ACAP1 and was accumulated in the recycling endosomes. CENTB1/ACAP1 is involved in the formation of clathrin coat complex that is regulated by ARF6 and also the cargo sorting of beta1-integirn that requires the phosphorylation of CENTB1/ACAP1 by Akt. Both are critical for beta1-integrin recycling. In contrast, CENTB2/ACAP2 did not have any inhibitory effects on beta1-integin recycling (98). There is another evidence that IQSEC1/BRAG2/GEP100 regulates beta1-integin endocytosis as well (94). The abrogation of IQSEC1/BRAG2/GEP100 expression by siRNA treatment resulted in an increase of beta1-integin at the cell surface along with more efficient and rapid spread of these cells on fibronectin-coated surfaces than control cells, suggesting the possibility that ARF6 is likely to be involved in the internalization of beta1-integin, as well as its recycling processes.

Integrin proteins are glycosylated and glycosylation is important in their cell adhesiveness and motility functions (99). Glycosylation is catalyzed by enzymes located in the Golgi appartus. In HeLa cells with knocked down ARFGEF1/BIG1, but not ARFGEP2/BIG2, aberrantly N-glycosylated beta1-integrin accumulates on the cell surface and these cells display an impairment in cell spreading and adhesion to extracellular matrix as well. Thus, it appears that class I ARFs and ARFGEF1/BIG1 are required for proper N-glycosylation of beta1-integin, affecting the functional activities of beta1-integin (100).

7.2. Filamin

Filamin A is a 280-kDa phosphoprotein that consists of two units, and cross-links actin filaments. Filamin A is widely expressed in many types of cells and regulates the reorganization of actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers.

Colocalization of ARFGEP2/GIB2, a GEF for class I ARFs, and Filamin A has been demonstrated in human neural stem cells. The overexpression of a dominant negative ARFGEF2/BIG2(E738K) in neuroblastoma cells results in partial blockade of Filamin A transport from the Golgi apparatus to cell membranes (101), suggesting that the trafficking of Filamin A from the Golgi to cell membrane is, in part, regulated by class I ARFs in neural cells. The trafficking of Filamin A in epithelial cells remains unclear.

7.3. Other proteins associated with focal adhesions

Paxillin is a signal transduction adaptor protein that localizes to FAs. Paxillin contains a number of motifs and interacts with many other proteins (102, 103). Paxillin binding proteins range from structural proteins, such as vinculin and actopaxin that bind actin directly, to regulatory proteins such as ARF GAP, p21-GTPase-activated kinase (PAK), PAK-Interactive exchange factor (PIX, GTP exchange factor for Rac1 and Cdc42). FAK is a protein tyrosine kinase that localizes to FAs, and plays a key role in the assembly and disassembly of FAs (91). FAK phosphorylates cortactin, and promotes polymerization and rearrangement of the actin cytoskeleton, which is important for lamellipodia and invadopodia formation as well as cell migration and endocytosis.

ARF1 has been shown to be involved in the recruitment of paxillin to FAs and the formation of FAs (82, 104). In COS7 cells, ARF6 activated by aluminum fluoride (AIF), changes subcellular distribution of paxillin leading to its colocalization with ARF6 at several membrane protrusions (105).

Furthermore, there is substantial evidence to show that ARF GAPs interact with several proteins associated the FAs, such as paxillin and FAK, and influence the dynamics and/or function of FAs. DDEF2/ASAP2/PAG3 directly binds to paxillin, and the overexpression of DDEF2/ASAP2/PAG3, but not its mutant lacking GAP activity, inhibits paxillin recruitment to FAs as well as cell migratory activity (105). The ARF GAP activity of CENTD1/ARAP2 or DDEF1/ASAP1/PAG2 has also been shown to influence the formation of FAs and cell spreading/migration activity (83, 106-108). In addition, DDEF1/ASAP1/PAG2 binds to FAK, tyrosin kinase Src or cortactin (83, 109, 110). Endogenous GIT1/p95-APP1/Cat1 colocalizes with paxillin at the cell periphery. The activation of GIT1/p95-APP1/Cat1 by its association with PIX, enhances its binding to paxillin and FAK, and leads to simultaneous disassembly of focal complexes and stimulation of cell motility (111). Moreover, GIT2/p95-APP2/Cat2 also localizes to FAs and binds to both paxillin and PIX as well. GIT2/p95-APP2/Cat2 mediates the association of paxillin and PAK-Nck-PIX complexes essential for PAK-dependent cytoskeleton reorganization such as lamellipodia formation (112). Many studies have also shown that GITs are involved in the formation and function of FAs (113, 114). Nonetheless, accumulating evidence has shown that ARFs and ARF GAPs play an important role in the dynamics of paxillin and FAK associated with FAs, resulting in the control of cell motility. However the precise regulatory mechanisms remain to be elucidated. Reader is referred to several excellent and comprehensive reviews that discuss the paxillin binding proteins including ARF GAPs in greater detail for a more comprehensive account (17, 51, 115, 116).

8. CYTOSKELETON

Cell-cell adhesions bear bulk of the mechanical stress in epithelial tissues. Intercellular junctions are generally associated with cytoskeletal molecules, such as actin and intermediate filaments that span across the cytoplasm of epithelial cells. This strengthens intercellular adherence and plays a pivotal role in the junction stability. As discussed above, some membrane proteins that are integral to cellular junctions, for example, E-cadherin and beta1-integrin, have been shown to shuttle between internalization to endosomal vesicles and recycling back to the plasma membrane, constitutively and/or in response to growth factor stimulation. These cellular processes require assembly/disassembly of cellular junctional complexes, and are thought be accompanied by rearrangement/remodeling of cytoskeletal proteins.

8.1. Actin

Actin filaments are found in the AJs, TJs and FAs. Individual subunits of actin are known as globular actin (G-actin). G-actin subunits assemble into long filamentous polymers called F-actin. The members of the Rho family of GTPases, including Rac1, RhoA and Cdc42, are well known for their regulation of actin cytoskeleton organization (117, 118). It has been shown that overexpression of a dominant active mutant of Rac1 promotes the accumulation of polymerized actin at cell-cell contacts and increases E-cadherin-mediated adhesion (119).

Several studies have shown that ARF1 and ARF6 are involved in actin dynamics. ARF1 regulates the recruitment of actin to the Golgi (24, 120-123). By contrast, ARF6 is implicated in the actin remodeling at cell periphery. ARF6-regulated actin remodeling is thought to be necessary for the formation of membrane ruffles (45, 46), neurite outgrowth (47, 48), cell spreading (37), cell migration (38, 105), and phagocytosis (34, 35). The effects of ARF6 on the actin cytoskeleton are likely to be mediated through the coordination and regulation of RhoA, Rac1 GTPase activity. Indeed, ARF6 activation promotes the downregulation of RhoA, resulting in reduced stress fiber formation (44) as well as the downregulation of Rac1-GTP levels, resulting in cell scattering (42). In addition to the regulation of Rac1 and/or RhoA activity, ARF6 has also been shown to promote membrane ruffling by directly interaction with POR1, a Rac1 interacting protein, independent from Rac1 activation (45). Furthermore, ARF6 modulates the actin cytoskeleton through its effect on lipid metabolism. ARF6 activates PLD and PIP5K (49, 50), and the activation of these enzymes can directly or indirectly lead to the accumulation of PI(4,5)P2, which has been shown to regulate actin capping as well as the activities of several actin-binding proteins (124, 125). Indeed, ARF6-induced PLD activity in concert with Rac1 activation promotes cell migration (38). It has been shown that ARF6 and PSD/EFA6 influence actin remodeling at the TJs (37, 40, 53). Both ARF6 activated by aluminum fluoride (AIF) and GTPase-deficient mutant ARF6(Q67L), but not ARF1, induce active membrane ruffles and protrusions in HeLa and COS cells. Upon AIF treatment, ARF6 also promotes redistribution of FAK and cortactin at the cell periphery where the formation of membrane ruffles and protrusions occur (46). The reduced expression of CENTD1/ARAP2, a GAP that regulates ARF6, by siRNA treatment results in loss of focal adhesions and actin stress fibers (106). These observations compellingly suggest that ARF6 enhances the actin remodeling at focal adhesions and are likely to be involved in the focal adhesion turnover and function.

8.2. Intermediate filament

In epithelia, keratin intermediate filaments form desmosomes or hemidesmosomes. In mesenchymal cellular stages, epithelial cells lose their epithelial characteristics including those of AJs and cell polarity, and acquire new mesenchymal cell phenotypes, such as the expression of vimentin. Vimentin is the most widely distributed of all intermediate filament proteins, and also found in cells derived from mesoderm, such as fibroblasts, leukocytes and endothelial cells (126). The expression of vimentin is thought to be important in cell migration.

It has been shown that BFA treatment induces changes in the organization of vimentin filaments, either through retraction to the perinuclear region or through the formation of elongated process-like formations. This effect is accompanied by the release of AP1 and AP3 adaptor complexes from membranes and the binding of these adaptor proteins to vimentin. A dominant-negative mutant of ARF1, ARF(T31N), but not wild-type ARF1 or a GTPase-deficient mutant ARF1(Q71L), showed the same effect on vimentin filaments, suggesting that ARF1 is likely to participates in the alteration of vimentin cytoskeleton on the Golgi (127).

9. CONCLUDING REMARKS

Since the original discovery of ARFs being critical cofactors for cholera toxin mediated ADP ribosylation of heterotrimeric G proteins, much has been learned about these important proteins. From a cell biology perspective, a clearer picture has emerged as to how these proteins play a pivotal role in the regulation of vesicle formation and transport. With their ability to regulate lipid modifying enzymes, these proteins can influence the very composition of phospholipid membranes and the cytoskeletal organization. We have made great strides in understanding how these ARF proteins participate and regulate many fundamental cellular processes including secretion, endocytosis, cell adhesions and epithelial integrity. In Table 3, I have summarized the known activities of ARFs in functional integrity of epithelia. In addition, we are beginning to unravel their involvement in processes such as wound healing, cellular transformation, tumor cell invasion and metastasis. One challenge has been to understand the complex and intricate mechanisms that regulate these ARF proteins spatially and temporally. The circuitry of diverse GEFs and/or GAPs and their regulation by upstream signaling remains incomplete. Thus, ARF proteins continue to represent a very fertile and exciting field for us to make new discoveries and expand our understanding of these versatile molecules from basic science to clinical medicine.

10. ACKNOWLEDGMENT

I apologize to investigators whose work was not cited here due to strict page limitations of this article.

11. REFERENCES

1. Braga VM and Yap AS: The challenges of abundance: epithelial junctions and small GTPase signalling. Curr Opin Cell Biol 17(5), 466-474 (2005) doi:10.1016/j.ceb.2005.08.012
http://dx.doi.org/10.1016/j.ceb.2005.08.012

2. Van Aelst L and Symons M: Role of Rho family GTPases in epithelial morphogenesis. Genes Dev 16(9), 1032-1054 (2002) doi:10.1101/gad.978802
http://dx.doi.org/10.1101/gad.978802

3. Wennerberg K, Rossman KL and Der CJ: The Ras superfamily at a glance. J Cell Sci 118(Pt 5), 843-846 (2005) doi:10.1242/jcs.01660
http://dx.doi.org/10.1242/jcs.01660

4. Kahn RA and Gilman AG: Purification of a protein cofactor required for ADP-ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera toxin. J Biol Chem 259(10), 6228-6234 (1984)

5. Kahn RA and Gilman AG: The protein cofactor necessary for ADP-ribosylation of Gs by cholera toxin is itself a GTP binding protein. J Biol Chem 261(17), 7906-7911 (1986)

6. D'Souza-Schorey C and Chavrier P: ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 7(5), 347-358 (2006) doi:10.1038/nrm1910
http://dx.doi.org/10.1038/nrm1910

7. Donaldson JG, Honda A and Weigert R: Multiple activities for Arf1 at the Golgi complex. Biochim Biophys Acta 1744(3), 364-373 (2005) doi:10.1016/j.bbamcr.2005.03.001
http://dx.doi.org/10.1016/j.bbamcr.2005.03.001

8. Donaldson JG: Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem 278(43), 41573-41576 (2003) doi:10.1074/jbc.R300026200
http://dx.doi.org/10.1074/jbc.R300026200

9. Jaworski J: ARF6 in the nervous system. Eur J Cell Biol 86(9), 513-524 (2007) doi:10.1016/j.ejcb.2007.04.007
http://dx.doi.org/10.1016/j.ejcb.2007.04.007

10. Burd CG, Strochlic TI and Gangi Setty SR: Arf-like GTPases: not so Arf-like after all. Trends Cell Biol 14(12), 687-694 (2004) doi:10.1016/j.tcb.2004.10.004
http://dx.doi.org/10.1016/j.tcb.2004.10.004

11. Gillingham AK and Munro S: The small G proteins of the Arf family and their regulators. Annu Rev Cell Dev Biol 23, 579-611 (2007) doi:10.1146/annurev.cellbio.23.090506.123209
http://dx.doi.org/10.1146/annurev.cellbio.23.090506.123209

12. Kahn RA, Cherfils J, Elias M, Lovering RC, Munro S and Schurmann A: Nomenclature for the human Arf family of GTP-binding proteins: ARF, ARL, and SAR proteins. J Cell Biol 172(5), 645-650 (2006) doi:10.1083/jcb.200512057
http://dx.doi.org/10.1083/jcb.200512057

13. Peyroche A, Antonny B, Robineau S, Acker J, Cherfils J and Jackson CL: Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain. Mol Cell 3(3), 275-285 (1999) doi:10.1016/S1097-2765(00)80455-4
http://dx.doi.org/10.1016/S1097-2765(00)80455-4

14. Renault L, Guibert B and Cherfils J: Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor. Nature 426(6966), 525-530 (2003) doi:10.1038/nature02197
http://dx.doi.org/10.1038/nature02197

15. Mossessova E, Corpina RA and Goldberg J: Crystal structure of ARF1*Sec7 complexed with Brefeldin A and its implications for the guanine nucleotide exchange mechanism. Mol Cell 12(6), 1403-1411 (2003) doi:10.1016/S1097-2765(03)00475-1
http://dx.doi.org/10.1016/S1097-2765(03)00475-1

16. Casanova JE: Regulation of Arf activation: the Sec7 family of guanine nucleotide exchange factors. Traffic 8(11), 1476-1485 (2007) doi:10.1111/j.1600-0854.2007.00634.x
http://dx.doi.org/10.1111/j.1600-0854.2007.00634.x

17. Inoue H and Randazzo PA: Arf GAPs and their interacting proteins. Traffic 8(11), 1465-1475 (2007) doi:10.1111/j.1600-0854.2007.00624.x
http://dx.doi.org/10.1111/j.1600-0854.2007.00624.x

18. Cukierman E, Huber I, Rotman M and Cassel D: The ARF1 GTPase-activating protein: zinc finger motif and Golgi complex localization. Science 270(5244), 1999-2002 (1995) doi:10.1126/science.270.5244.1999
http://dx.doi.org/10.1126/science.270.5244.1999

19. Huber I, Cukierman E, Rotman M, Aoe T, Hsu VW, Cassel D: Requirement for both the amino-terminal catalytic domain and a noncatalytic domain for in vivo activity of ADP-ribosylation factor GTPase-activating protein. J Biol Chem 273(38), 24786-24791 (1998) doi:10.1074/jbc.273.38.24786

http://dx.doi.org/10.1074/jbc.273.38.24786

20. Balch WE, Kahn RA and Schwaninger R: ADP-ribosylation factor is required for vesicular trafficking between the endoplasmic reticulum and the cis-Golgi compartment. J Biol Chem 267(18), 13053-13061 (1992)

21. Ooi CE, Dell'Angelica EC and Bonifacino JS: ADP-Ribosylation factor 1 (ARF1) regulates recruitment of the AP-3 adaptor complex to membranes. J Cell Biol 142(2), 391-402 (1998) doi:10.1083/jcb.142.2.391
http://dx.doi.org/10.1083/jcb.142.2.391

22. Altan-Bonnet N, Phair RD, Polishchuk RS, Weigert R and Lippincott-Schwartz J: A role for Arf1 in mitotic Golgi disassembly, chromosome segregation, and cytokinesis. Proc Natl Acad Sci U S A 100(23), 13314-13319 (2003) doi:10.1073/pnas.2234055100
http://dx.doi.org/10.1073/pnas.2234055100

23. Dascher C and Balch WE: Dominant inhibitory mutants of ARF1 block endoplasmic reticulum to Golgi transport and trigger disassembly of the Golgi apparatus. J Biol Chem 269(2), 1437-1448 (1994)

24. Cao H, Weller S, Orth JD, Chen J, Huang B, Chen JL, Stamnes M and McNiven MA: Actin and Arf1-dependent recruitment of a cortactin-dynamin complex to the Golgi regulates post-Golgi transport. Nat Cell Biol 7(5), 483-492 (2005) doi:10.1038/ncb1246
http://dx.doi.org/10.1038/ncb1246

25. Godi A, Pertile P, Meyers R, Marra P, Di Tullio G., Iurisci C, Luini A, Corda D and De Matteis MA: ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat Cell Biol 1(5), 280-287 (1999) doi:10.1038/12993
http://dx.doi.org/10.1038/12993

26. Haynes LP, Thomas GM and Burgoyne RD: Interaction of neuronal calcium sensor-1 and ADP-ribosylation factor 1 allows bidirectional control of phosphatidylinositol 4-kinase beta and trans-Golgi network-plasma membrane traffic. J Biol Chem 280(7), 6047-6054 (2005) doi:10.1074/jbc.M413090200
http://dx.doi.org/10.1074/jbc.M413090200

27. D'Souza-Schorey C, Li G, Colombo MI and Stahl PD: A regulatory role for ARF6 in receptor-mediated endocytosis. Science 267(5201), 1175-1178 (1995) doi:10.1126/science.7855600
http://dx.doi.org/10.1126/science.7855600

28. Altschuler Y, Liu S, Katz L, Tang K, Hardy S, Brodsky F, Apodaca G and Mostov K: ADP-ribosylation factor 6 and endocytosis at the apical surface of Madin-Darby canine kidney cells. J Cell Biol 147(1), 7-12 (1999) doi:10.1083/jcb.147.1.7
http://dx.doi.org/10.1083/jcb.147.1.7

29. Claing A, Chen W, Miller WE, Vitale N, Moss J, Premont RT and Lefkowitz RJ: beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis. J Biol Chem 276(45), 42509-42513 (2001) doi:10.1074/jbc.M108399200
http://dx.doi.org/10.1074/jbc.M108399200

30. Delaney KA, Murph MM, Brown LM and Radhakrishna H: Transfer of M2 muscarinic acetylcholine receptors to clathrin-derived early endosomes following clathrin-independent endocytosis. J Biol Chem 277(36), 33439-33446 (2002) doi:10.1074/jbc.M205293200
http://dx.doi.org/10.1074/jbc.M205293200

31. Galas MC, Helms JB, Vitale N, Thiersé D, Aunis D and Bader MF: Regulated exocytosis in chromaffin cells. A potential role for a secretory granule-associated ARF6 protein. J Biol Chem 272(5), 2788-2793 (1997) doi:10.1074/jbc.272.5.2788
http://dx.doi.org/10.1074/jbc.272.5.2788

32. Matsukawa J, Nakayama K, Nagao T, Ichijo H and Urushidani T: Role of ADP-ribosylation factor 6 (ARF6) in gastric acid secretion. J Biol Chem 278(38), 36470-36475 (2003) doi:10.1074/jbc.M305444200
http://dx.doi.org/10.1074/jbc.M305444200

33. Lawrence JT and Birnbaum MJ: ADP-ribosylation factor 6 regulates insulin secretion through plasma membrane phosphatidylinositol 4,5-bisphosphate. Proc Natl Acad Sci U S A 100(23), 13320-13325 (2003) doi:10.1073/pnas.2232129100
http://dx.doi.org/10.1073/pnas.2232129100

34. Zhang Q, Cox D, Tseng CC, Donaldson JG and Greenberg S.: A requirement for ARF6 in Fcgamma receptor-mediated phagocytosis in macrophages. J Biol Chem. 273(32), 19977-19981 (1998) doi:10.1074/jbc.273.32.19977
http://dx.doi.org/10.1074/jbc.273.32.19977

35. Niedergang F, Colucci-Guyon E, Dubois T, Raposo G and Chavrier P.: ADP ribosylation factor 6 is activated and controls membrane delivery during phagocytosis in macrophages. J Cell Biol. 161(6), 1143-1150 (2003) doi:10.1083/jcb.200210069
http://dx.doi.org/10.1083/jcb.200210069

36. Uchida H, Kondo A, Yoshimura Y, Mazaki Y and Sabe H: PAG3/Papalpha/KIAA0400, a GTPase-activating protein for ADP-ribosylation factor (ARF), regulates ARF6 in Fcgamma receptor-mediated phagocytosis of macrophages. J Exp Med 193(8), 955-966 (2001) doi:10.1084/jem.193.8.955
http://dx.doi.org/10.1084/jem.193.8.955

37. Palacios F, Price L, Schweitzer J, Collard JG and D'Souza-Schorey C: An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J 20(17), 4973-4986 (2001) doi:10.1093/emboj/20.17.4973
http://dx.doi.org/10.1093/emboj/20.17.4973

38. Santy LC and Casanova JE: Activation of ARF6 by ARNO stimulates epithelial cell migration through downstream activation of both Rac1 and phospholipase D. J Cell Biol 154(3), 599-610 (2001) doi:10.1083/jcb.200104019
http://dx.doi.org/10.1083/jcb.200104019

39. Weber KS, Weber C, Ostermann G, Dierks H, Nagel W and Kolanus W: Cytohesin-1 is a dynamic regulator of distinct LFA-1 functions in leukocyte arrest and transmigration triggered by chemokines. Curr Biol 11(24), 1969-1974 (2001) doi:10.1016/S0960-9822(01)00597-8
http://dx.doi.org/10.1016/S0960-9822(01)00597-8

40. Santy LC: Characterization of a fast cycling ADP-ribosylation factor 6 mutant. J Biol Chem 277(43), 40185-40188 (2002) doi:10.1074/jbc.C200481200
http://dx.doi.org/10.1074/jbc.C200481200

41. Song J, Khachikian Z, Radhakrishna H and Donaldson JG: Localization of endogenous ARF6 to sites of cortical actin rearrangement and involvement of ARF6 in cell spreading. J Cell Sci 111(Pt 15), 2257-2267 (1998)

42. Palacios F and D'Souza-Schorey C: Modulation of Rac1 and ARF6 activation during epithelial cell scattering. J Biol Chem 278(19), 17395-17400 (2003) doi:10.1074/jbc.M300998200
http://dx.doi.org/10.1074/jbc.M300998200

43. Radhakrishna H, Al-Awar O, Khachikian Z and Donaldson JG: ARF6 requirement for Rac ruffling suggests a role for membrane trafficking in cortical actin rearrangements. J Cell Sci 112 (Pt 6), 855-866 (1999)

44. Boshans RL, Szanto S, van Aelst L and D'Souza-Schorey C: ADP-ribosylation factor 6 regulates actin cytoskeleton remodeling in coordination with Rac1 and RhoA. Mol Cell Biol 20(10), 3685-3694 (2000) doi:10.1128/MCB.20.10.3685-3694.2000
http://dx.doi.org/10.1128/MCB.20.10.3685-3694.2000

45. D'Souza-Schorey C, Boshans RL, McDonough M, Stahl PD and Van Aelst L: A role for POR1, a Rac1-interacting protein, in ARF6-mediated cytoskeletal rearrangements. EMBO J 16(17), 5445-5454 (1997) doi:10.1093/emboj/16.17.5445
http://dx.doi.org/10.1093/emboj/16.17.5445

46. Radhakrishna H, Klausner RD and Donaldson JG: Aluminum fluoride stimulates surface protrusions in cells overexpressing the ARF6 GTPase. J Cell Biol 134(4), 935-947 (1996) doi:10.1083/jcb.134.4.935
http://dx.doi.org/10.1083/jcb.134.4.935

47. Albertinazzi C, Za L, Paris S and de Curtis I: ADP-ribosylation factor 6 and a functional PIX-p95-APP1 complex are required for Rac1B-mediated neurite outgrowth. Mol Biol Cell 14(4), 1295-1307 (2003) doi:10.1091/mbc.E02-07-0406
http://dx.doi.org/10.1091/mbc.E02-07-0406

48. Hernandez-Deviez DJ, Roth MG, Casanova JE and Wilson JM: ARNO and ARF6 regulate axonal elongation and branching through downstream activation of phosphatidylinositol 4-phosphate 5-kinase alpha. Mol Biol Cell 15(1), 111-120 (2004) doi:10.1091/mbc.E03-06-0410
http://dx.doi.org/10.1091/mbc.E03-06-0410

49. Brown HA, Gutowski S, Moomaw CR, Slaughter C and Sternweis PC: ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity. Cell 75(6), 1137-1144 (1993) doi:10.1016/0092-8674(93)90323-I
http://dx.doi.org/10.1016/0092-8674(93)90323-I

50. Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H, Watanabe H, Kawamoto K, Nakayama K, Morris AJ, Frohman MA and Kanaho Y: Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell 99(5), 521-532 (1999) doi:10.1016/S0092-8674(00)81540-8
http://dx.doi.org/10.1016/S0092-8674(00)81540-8

51. Randazzo PA, Inoue H and Bharti S: Arf GAPs as regulators of the actin cytoskeleton. Biol Cell 99(10), 583-600 (2007)

52. Shin K, Fogg VC and Margolis B: Tight junctions and cell polarity. Annu Rev Cell Dev Biol 22, 207-235 (2006) doi:10.1146/annurev.cellbio.22.010305.104219
http://dx.doi.org/10.1146/annurev.cellbio.22.010305.104219

53. Luton F, Klein S, Chauvin JP, Le Bivic A, Bourgoin S, Franco M and Chardin P: EFA6, exchange factor for ARF6, regulates the actin cytoskeleton and associated tight junction in response to E-cadherin engagement. Mol Biol Cell 15(3), 1134-1145 (2004) doi:10.1091/mbc.E03-10-0751
http://dx.doi.org/10.1091/mbc.E03-10-0751

54. Shultz T, Nash-Livni N, Shmuel M and Altschuler Y: EFA6 regulates endosomal trafficking and affects early endosomes in polarized MDCK cells. Biochem Biophys Res Commun 351(1), 106-112 (2006) doi:10.1016/j.bbrc.2006.10.024
http://dx.doi.org/10.1016/j.bbrc.2006.10.024

55. Franco M, Peters PJ, Boretto J, van Donselaar E, Neri A, D'Souza-Schorey C and Chavrier P: EFA6, a sec7 domain-containing exchange factor for ARF6, coordinates membrane recycling and actin cytoskeleton organization. EMBO J 18(6), 1480-1491 (1999) doi:10.1093/emboj/18.6.1480
http://dx.doi.org/10.1093/emboj/18.6.1480

56. Derrien V, Couillault C, Franco M, Martineau S, Montcourrier P, Houlgatte R and Chavrier P: A conserved C-terminal domain of EFA6-family ARF6-guanine nucleotide exchange factors induces lengthening of microvilli-like membrane protrusions. J Cell Sci 115(Pt 14), 2867-2879 (2002)

57. Niessen CM: Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 127(11), 2525-2532 (2007) doi:10.1038/sj.jid.5700865
http://dx.doi.org/10.1038/sj.jid.5700865

58. Bryant DM and Stow JL: The ins and outs of E-cadherin trafficking. Trends Cell Biol 14(8), 427-434 (2004) doi:10.1016/j.tcb.2004.07.007
http://dx.doi.org/10.1016/j.tcb.2004.07.007

59. Palacios F, Schweitzer JK, Boshans RL and D'Souza-Schorey C: ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat Cell Biol 4(12), 929-936 (2002) doi:10.1038/ncb881
http://dx.doi.org/10.1038/ncb881

60. Le TL, Yap AS and Stow JL: Recycling of E-cadherin: a potential mechanism for regulating cadherin dynamics. J Cell Biol 146(1), 219-232 (1999) doi:10.1083/jcb.146.1.219
http://dx.doi.org/10.1083/jcb.146.1.219

61. Paterson AD, Parton RG, Ferguson C, Stow JL and Yap AS: Characterization of E-cadherin endocytosis in isolated MCF-7 and chinese hamster ovary cells: the initial fate of unbound E-cadherin. J Biol Chem 278(23), 21050-21057 (2003) doi:10.1074/jbc.M300082200
http://dx.doi.org/10.1074/jbc.M300082200

62. Akhtar N and Hotchin NA: RAC1 regulates adherens junctions through endocytosis of E-cadherin. Mol Biol Cell 12(4), 847-862 (2001)

63. Yap AS: The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review. Cancer Invest 16(4), 252-261 (1998) doi:10.3109/07357909809039774
http://dx.doi.org/10.3109/07357909809039774

64. Braga VM, Machesky LM, Hall A and Hotchin NA: The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J Cell Biol 137(6), 1421-1431 (1997) doi:10.1083/jcb.137.6.1421
http://dx.doi.org/10.1083/jcb.137.6.1421

65. Hordijk PL, ten Klooster JP, van der Kammen RA, Michiels F, Oomen LC and Collard JG: Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 278(5342), 1464-1466 (1997) doi:10.1126/science.278.5342.1464
http://dx.doi.org/10.1126/science.278.5342.1464

66. Noren NK, Niessen CM, Gumbiner BM and Burridge K: Cadherin engagement regulates Rho family GTPases. J Biol Chem 276(36), 33305-33308 (2001) doi:10.1074/jbc.C100306200
http://dx.doi.org/10.1074/jbc.C100306200

67. Someya A, Sata M, Takeda K, Pacheco-Rodriguez G, Ferrans VJ, Moss J and Vaughan M: ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6. Proc Natl Acad Sci U S A 98(5), 2413-2418 (2001) doi:10.1073/pnas.051634798
http://dx.doi.org/10.1073/pnas.051634798

68. Hiroi T, Someya A, Thompson W, Moss J and Vaughan M: GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin. Proc Natl Acad Sci U S A 103(28), 10672-10677 (2006) doi:10.1073/pnas.0604091103
http://dx.doi.org/10.1073/pnas.0604091103

69. Morishige M, Hashimoto S, Ogawa E, Toda Y, Kotani H, Hirose M, Wei S, Hashimoto A, Yamada A, Yano H, Mazaki Y, Kodama H, Nio Y, Manabe T, Wada H, Kobayashi H and Sabe H: GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol 10(1), 85-92 (2008) doi:10.1038/ncb1672
http://dx.doi.org/10.1038/ncb1672

70. Sheen VL, Ganesh VS, Topcu M, Sebire G, Bodell A, Hill RS, Grant PE, Shugart YY, Imitola J, Khoury SJ, Guerrini R and Walsh CA: Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nat Genet 36(1), 69-76 (2004) doi:10.1038/ng1276
http://dx.doi.org/10.1038/ng1276

71. Shin HW, Morinaga N, Noda M and Nakayama K: BIG2, a guanine nucleotide exchange factor for ADP-ribosylation factors: its localization to recycling endosomes and implication in the endosome integrity. Mol Biol Cell 15(12), 5283-5294 (2004) doi:10.1091/mbc.E04-05-0388
http://dx.doi.org/10.1091/mbc.E04-05-0388

72. Gates J and Peifer M: Can 1000 reviews be wrong? Actin, alpha-Catenin, and adherens junctions. Cell 123(5), 769-772 (2005) doi:10.1016/j.cell.2005.11.009
http://dx.doi.org/10.1016/j.cell.2005.11.009

73. Yamada S, Pokutta S, Drees F, Weis WI and Nelson WJ: Deconstructing the cadherin-catenin-actin complex. Cell 123, 889-901 (2005) doi:10.1016/j.cell.2005.09.020
http://dx.doi.org/10.1016/j.cell.2005.09.020

74. Drees F, Pokutta S, Yamada S, Nelson WJ and Weis WI: Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 123, 903-915 (2005) doi:10.1016/j.cell.2005.09.021
http://dx.doi.org/10.1016/j.cell.2005.09.021

75. Johnson RP and Craig SW: The carboxy-terminal tail domain of vinculin contains a cryptic binding site for acidic phospholipids. Biochem Biophys Res Commun 210(1), 159-164 (1995) doi:10.1006/bbrc.1995.1641
http://dx.doi.org/10.1006/bbrc.1995.1641

76. Gilmore AP and Burridge K: Regulation of vinculin binding to talin and actin by phosphatidyl-inositol-4-5-bisphosphate. Nature 381(6582), 531-535 (1996) doi:10.1038/381531a0
http://dx.doi.org/10.1038/381531a0

77. Weekes J, Barry ST and Critchley DR: Acidic phospholipids inhibit the intramolecular association between the N- and C-terminal regions of vinculin, exposing actin-binding and protein kinase C phosphorylation sites. Biochem J 314 (Pt 3), 827-832 (1996)

78. Corgan AM, Singleton C, Santoso CB and Greenwood JA: Phosphoinositides differentially regulate alpha-actinin flexibility and function. Biochem J 378(Pt 3), 1067-1072 (2004) doi:10.1042/BJ20031124
http://dx.doi.org/10.1042/BJ20031124

79. Fukami K, Furuhashi K, Inagaki M, Endo T, Hatano S and Takenawa T: Requirement of phosphatidylinositol 4,5-bisphosphate for alpha-actinin function. Nature 359(6391), 150-152 (1992) doi:10.1038/359150a0
http://dx.doi.org/10.1038/359150a0

80. Lee S, Park JB, Kim JH, Kim Y, Kim JH, Shin KJ, Lee JS, Ha SH, Suh PG and Ryu SH: Actin directly interacts with phospholipase D, inhibiting its activity. J Biol Chem 276(30), 28252-28260 (2001) doi:10.1074/jbc.M008521200
http://dx.doi.org/10.1074/jbc.M008521200

81. Park JB, Kim JH, Kim Y, Ha SH, Yoo JS, Du G, Frohman MA, Suh PG and Ryu SH: Cardiac phospholipase D2 localizes to sarcolemmal membranes and is inhibited by alpha-actinin in an ADP-ribosylation factor-reversible manner. J Biol Chem 275(28), 21295-21301 (2000) doi:10.1074/jbc.M002463200
http://dx.doi.org/10.1074/jbc.M002463200

82. Norman JC, Jones D, Barry ST, Holt MR, Cockcroft S and Critchley DR: ARF1 mediates paxillin recruitment to focal adhesions and potentiates Rho-stimulated stress fiber formation in intact and permeabilized Swiss 3T3 fibroblasts. J Cell Biol 143(7), 1981-1995 (1998) doi:10.1083/jcb.143.7.1981
http://dx.doi.org/10.1083/jcb.143.7.1981

83. Liu Y, Loijens JC, Martin KH, Karginov AV and Parsons JT: The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. Mol Biol Cell 13(6), 2147-2156 (2002) doi:10.1091/mbc.E02-01-0018
http://dx.doi.org/10.1091/mbc.E02-01-0018

84. Sakagami H, Honma T, Sukegawa J, Owada Y, Yanagisawa T and Kondo H: Somatodendritic localization of EFA6A, a guanine nucleotide exchange factor for ADP-ribosylation factor 6, and its possible interaction with alpha-actinin in dendritic spines. Eur J Neurosci 25(3), 618-628 (2007) doi:10.1111/j.1460-9568.2007.05345.x
http://dx.doi.org/10.1111/j.1460-9568.2007.05345.x

85. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ and Frohman MA: Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 7(3), 191-201 (1997) doi:10.1016/S0960-9822(97)70090-3
http://dx.doi.org/10.1016/S0960-9822(97)70090-3

86. Green KJ and Simpson CL: Desmosomes: new perspectives on a classic. J Invest Dermatol 127(11), 2499-2515 (2007) doi:10.1038/sj.jid.5701015
http://dx.doi.org/10.1038/sj.jid.5701015

87. Naslavsky N, Weigert R and Donaldson JG: Convergence of non-clathrin- and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides. Mol Biol Cell 14(2), 417-431 (2003) doi:10.1091/mbc.02-04-0053
http://dx.doi.org/10.1091/mbc.02-04-0053

88. Radhakrishna H and Donaldson JG: ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway. J Cell Biol 139(1), 49-61 (1997) doi:10.1083/jcb.139.1.49
http://dx.doi.org/10.1083/jcb.139.1.49

89. Mukherjee S, Gurevich VV, Jones JC, Casanova JE, Frank SR, Maizels ET, Bader MF, Kahn RA, Palczewski K, Aktories K and Hunzicker-Dunn M: The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization. Proc Natl Acad Sci U S A 97(11), 5901-5906 (2000) doi:10.1073/pnas.100127097
http://dx.doi.org/10.1073/pnas.100127097

90. Brown FD, Rozelle AL, Yin HL, Balla T and Donaldson JG: Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J Cell Biol 154(5), 1007-1017 (2001) doi:10.1083/jcb.200103107
http://dx.doi.org/10.1083/jcb.200103107

91. Mitra SK, Hanson DA and Schlaepfer DD: Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6(1), 56-68 (2005) doi:10.1038/nrm1549
http://dx.doi.org/10.1038/nrm1549

92. Pellinen T and Ivaska J: Integrin traffic. J Cell Sci 119(Pt 18), 3723-3731 (2006) doi:10.1242/jcs.03216
http://dx.doi.org/10.1242/jcs.03216

93. Powelka AM, Sun J, Li J, Gao M, Shaw LM, Sonnenberg A and Hsu VW: Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic 5(1), 20-36 (2004) doi:10.1111/j.1600-0854.2004.00150.x
http://dx.doi.org/10.1111/j.1600-0854.2004.00150.x

94. Dunphy JL, Moravec R, Ly K, Lasell TK, Melancon P and Casanova JE: The Arf6 GEF GEP100/BRAG2 regulates cell adhesion by controlling endocytosis of beta1 integrins. Curr Biol 16(3), 315-320 (2006) doi:10.1016/j.cub.2005.12.032
http://dx.doi.org/10.1016/j.cub.2005.12.032

95. Jackson TR, Brown FD, Nie Z, Miura K, Foroni L, Sun J, Hsu VW, Donaldson JG and Randazzo PA: ACAPs are arf6 GTPase-activating proteins that function in the cell periphery. J Cell Biol 151(3), 627-638 (2000) doi:10.1083/jcb.151.3.627
http://dx.doi.org/10.1083/jcb.151.3.627

96. Li J, Peters PJ, Bai M, Dai J, Bos E, Kirchhausen T, Kandror KV and Hsu VW: An ACAP1-containing clathrin coat complex for endocytic recycling. J Cell Biol 178(3), 453-464 (2007) doi:10.1083/jcb.200608033
http://dx.doi.org/10.1083/jcb.200608033

97. Dai J, Li J, Bos E, Porcionatto M, Premont RT, Bourgoin S, Peters PJ and Hsu VW: ACAP1 promotes endocytic recycling by recognizing recycling sorting signals. Dev Cell 7(5), 771-776 (2004) doi:10.1016/j.devcel.2004.10.002
http://dx.doi.org/10.1016/j.devcel.2004.10.002

98. Li J, Ballif BA, Powelka AM, Dai J, Gygi SP and Hsu VW: Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration. Dev Cell 9(5), 663-673 (2005) doi:10.1016/j.devcel.2005.09.012
http://dx.doi.org/10.1016/j.devcel.2005.09.012

99. Bellis SL: Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins. Biochim Biophys Acta 1663(1-2), 52-60 (2004) doi:10.1016/j.bbamem.2004.03.012
http://dx.doi.org/10.1016/j.bbamem.2004.03.012

100. Shen X, Hong MS, Moss J and Vaughan M: BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1. Proc Natl Acad Sci U S A 104(4), 1230-1235 (2007) doi:10.1073/pnas.0610535104
http://dx.doi.org/10.1073/pnas.0610535104

101. Lu J, Tiao G, Folkerth R, Hecht J, Walsh C and Sheen V: Overlapping expression of ARFGEF2 and Filamin A in the neuroependymal lining of the lateral ventricles: insights into the cause of periventricular heterotopia. J Comp Neurol 494(3), 476-484 (2006) doi:10.1002/cne.20806
http://dx.doi.org/10.1002/cne.20806

102. Schaller MD: Paxillin: a focal adhesion-associated adaptor protein. Oncogene 20(44), 6459-6472 (2001) doi:10.1038/sj.onc.1204786
http://dx.doi.org/10.1038/sj.onc.1204786

103. Turner CE: Paxillin and focal adhesion signalling. Nat Cell Biol 2(12), E231-236 (2000) doi:10.1038/35046659
http://dx.doi.org/10.1038/35046659

104. Luo R, Jacques K, Ahvazi B, Stauffer S, Premont RT and Randazzo PA: Mutational analysis of the Arf1*GTP/Arf GAP interface reveals an Arf1 mutant that selectively affects the Arf GAP ASAP1. Curr Biol 15(23), 2164-2169 (2005) doi:10.1016/j.cub.2005.10.065
http://dx.doi.org/10.1016/j.cub.2005.10.065

105. Kondo A, Hashimoto S, Yano H, Nagayama K, Mazaki Y and Sabe H: A new paxillin-binding protein, PAG3/Papα/KIAA0400, bearing an ADP-ribosylation factor GTPase-activating protein activity, is involved in paxillin recruitment to focal adhesions and cell migration. Mol Biol Cell 11(4), 1315-1327 (2000)

106. Yoon HY, Miura K, Cuthbert EJ, Davis KK, Ahvazi B, Casanova JE and Randazzo PA: ARAP2 effects on the actin cytoskeleton are dependent on Arf6-specific GTPase-activating-protein activity and binding to RhoA-GTP. J Cell Sci 119(Pt 22), 4650-4666 (2006) doi:10.1242/jcs.03237
http://dx.doi.org/10.1242/jcs.03237

107. Liu Y, Yerushalmi GM, Grigera PR and Parsons JT: Mislocalization or reduced expression of Arf GTPase-activating protein ASAP1 inhibits cell spreading and migration by influencing Arf1 GTPase cycling. J Biol Chem 280(10), 8884-8892 (2005) doi:10.1074/jbc.M412200200
http://dx.doi.org/10.1074/jbc.M412200200

108. Furman C, Short SM, Subramanian RR, Zetter BR and Roberts TM: DEF-1/ASAP1 is a GTPase-activating protein (GAP) for ARF1 that enhances cell motility through a GAP-dependent mechanism. J Biol Chem 277(10), 7962-7969 (2002) doi:10.1074/jbc.M109149200
http://dx.doi.org/10.1074/jbc.M109149200

109. Onodera Y, Hashimoto S, Hashimoto A, Morishige M, Mazaki Y, Yamada A, Ogawa E, Adachi M, Sakurai T, manabe T, Wasa H, Masura N and Sabe H: Expression of AMAP1, an Arf GAP, provides novel targets to inhibit breast cancer invasive activiteies. EMBO J 24(5), 963-973 (2005) doi:10.1038/sj.emboj.7600588
http://dx.doi.org/10.1038/sj.emboj.7600588

110. Brown MT, Andrade J, Radhakrishna H, Donaldson JG, Cooper JA, Randazzo PA: ASAP1, a phospholipid-dependent arf GTPase-activating protein that associates with and is phosphorylated by Src. Mol Cell Biol 18(12), 7038-7051 (1998)

111. Zhao ZS, Manser E, Loo TH and Lim L: Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly. Mol Cell Biol 20(17), 6354-6363 (2000) doi:10.1128/MCB.20.17.6354-6363.2000
http://dx.doi.org/10.1128/MCB.20.17.6354-6363.2000

112. Turner CE, Brown MC, Perrotta JA, Riedy MC, Nikolopoulos SN, McDonald AR, Bagrodia S, Thomas S and Leventhal PS: Paxillin LD4 motif binds PAK and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein: a role in cytoskeletal remodeling. J Cell Biol 145(4), 851-863 (1999) doi:10.1083/jcb.145.4.851
http://dx.doi.org/10.1083/jcb.145.4.851

113. Frank SR, Adelstein MR and Hansen SH: GIT2 represses Crk- and Rac1-regulated cell spreading and Cdc42-mediated focal adhesion turnover. EMBO J 25(9), 1848-1859 (2006) doi:10.1038/sj.emboj.7601092
http://dx.doi.org/10.1038/sj.emboj.7601092

114. Nishiya N, Kiosses WB, Han J, Ginsberg MH: An alpha4 integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cells. Nat Cell Biol 7(4), 343-352 (2005) doi:10.1038/ncb1234
http://dx.doi.org/10.1038/ncb1234

115. Turner CE, West KA and Brown MC: Paxillin-ARF GAP signaling and the cytoskeleton. Curr Opin Cell Biol 13(5), 593-599 (2001) doi:10.1016/S0955-0674(00)00256-8
http://dx.doi.org/10.1016/S0955-0674(00)00256-8

116. de Curtis I: Cell migration: GAPs between membrane traffic and the cytoskeleton. EMBO Rep 2(4), 277-281 (2001) doi:10.1093/embo-reports/kve072
http://dx.doi.org/10.1093/embo-reports/kve072

117. Kaverina I, Krylyshkina O and Small JV: Regulation of substrate adhesion dynamics during cell motility. Int J Biochem Cell Biol 34(7), 746-761 (2002) doi:10.1016/S1357-2725(01)00171-6
http://dx.doi.org/10.1016/S1357-2725(01)00171-6

118. Ridley AJ: Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16(10), 522-529 (2006) doi:10.1016/j.tcb.2006.08.006
http://dx.doi.org/10.1016/j.tcb.2006.08.006

119. Takaishi K, Sasaki T, Kotani H, Nishioka H and Takai Y: Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells. J Cell Biol 139(4), 1047-1059 (1997) doi:10.1083/jcb.139.4.1047
http://dx.doi.org/10.1083/jcb.139.4.1047

120. Ménétrey J, Perderiset M, Cicolari J, Dubois T, Elkhatib N, El Khadali F, Franco M, Chavrier P and Houdusse A: Structural basis for ARF1-mediated recruitment of ARHGAP21 to Golgi membranes. EMBO J 26(7), 1953-1962 (2007) doi:10.1038/sj.emboj.7601634
http://dx.doi.org/10.1038/sj.emboj.7601634

121. Dubois T, Paléotti O, Mironov AA, Fraisier V, Stradal TE, De Matteis MA, Franco M and Chavrier P: Golgi-localized GAP for Cdc42 functions downstream of ARF1 to control Arp2/3 complex and F-actin dynamics. Nat Cell Biol 7(4), 353-364 (2005) doi:10.1038/ncb1244
http://dx.doi.org/10.1038/ncb1244

122. Fucini RV, Navarrete A, Vadakkan C, Lacomis L, Erdjument-Bromage H, Tempst P and Stamnes M: Activated ADP-ribosylation factor assembles distinct pools of actin on golgi membranes. J Biol Chem 275(25), 18824-18829 (2000) doi:10.1074/jbc.M000024200
http://dx.doi.org/10.1074/jbc.M000024200

123. Fucini RV, Chen JL, Sharma C, Kessels MM and Stamnes M: Golgi vesicle proteins are linked to the assembly of an actin complex defined by mAbp1. Mol Biol Cell 13(2), 621-631 (2002) doi:10.1091/mbc.01-11-0547
http://dx.doi.org/10.1091/mbc.01-11-0547

124. Mao YS and Yin HL: Regulation of the actin cytoskeleton by phosphatidylinositol 4-phosphate 5 kinases. Pflugers Arch 455(1), 5-18 (2007) doi:10.1007/s00424-007-0286-3
http://dx.doi.org/10.1007/s00424-007-0286-3

125. Yin HL and Janmey PA; Phosphoinositide regulation of the actin cytoskeleton. Annu Rev Physiol 65, 761-789 (2003) doi:10.1146/annurev.physiol.65.092101.142517
http://dx.doi.org/10.1146/annurev.physiol.65.092101.142517

126. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15(6), 740-746 (2003) doi:10.1016/j.ceb.2003.10.006
http://dx.doi.org/10.1016/j.ceb.2003.10.006

127. Styers ML, Kowalczyk AP and Faundez V: Architecture of the vimentin cytoskeleton is modified by perturbation of the GTPase ARF1. J Cell Sci 119(Pt 17), 3643-3654 (2006) doi:10.1242/jcs.03147
http://dx.doi.org/10.1242/jcs.03147

Abbreviations: ARF, ADP-ribosylation factor; GEF, guanine nucleotide exchange factors; GAP, GTPase-activating proteins; TJ, tight junction; AJ, adherens junctions; FA, focal adhesions/contacts; BFA, brefeldin A; MDCK, Madin-Darby canine kidney; HGF, hepatocyte growth factor; EGF, epidermal growth factor; PI(4,5)P2, phosphatidylinosital (4, 5)-bisphosphate; PLD, phospholipase D; PIP5K, type I phosphatidylinositol phosphate 5 kinase; MHC I, major histocompatibility complex class I; ECM, extracellular matrix; FAK, focal adhesion kinase FAK; PAK, p21-GTPase-activated kinase; PIX, PAK-Interactive exchange factor; AIF, aluminum fluoride

Key Words: ADP-ribosylation factor, epithelial adherens, E-cadherin, beta1-integrin, actin cytoskeleton, cell motility

Send correspondence to: Toyoko Hiroi, Division of Cardiology, Johns Hopkins University School of Medicine, 1721 East Madison Street, Ross Research Building 1167, Baltimore, MD 21205, Tel: 410-502-1717, E-mail:thiroi1@jhmi.edu